课题基金 / 基金详情

Developing Biomechanical Predictors of Ascending Thoracic Aortic Aneurysm Growth and Dissection

Developing Biomechanical Predictors of Ascending Thoracic Aortic Aneurysm Growth and Dissection
开发升胸主动脉瘤生长和夹层的生物力学预测因子
批准号:
10614562
负责人:
Elaine Evelina Tseng
金额:
$0.0万
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
未结题
起止时间:
2022-04-01 至 2026-03-31

项目摘要

项目成果

Elaine Evelina Tseng的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Veterans Affairs (VA) Healthcare System services >9 million veterans at 144 hospitals nationwide. Aortic aneurysms are the 16th leading cause of death in patients >35 years old in the United States. Dissection and rupture of aTAAs are catastrophic cardiovascular emergencies carrying significant pre-hospital (40%) and operative (17-25%) mortality. Surgical guidelines rely on aTAA maximum diameter, growth rate, and symptoms to guide elective repair, which can be performed with low operative mortality. However, we and others have demonstrated that diameter alone is not adequate to predict dissection or rupture—~60-90% of type A dissection events occur in aTAAs with diameter <5.5cm and otherwise not meeting elective surgical repair indications. From a biomechanics perspective, rupture or dissection is a mechanical failure that can occur when aneurysm wall stress exceeds wall strength. Guidelines simply use diameter as a surrogate for wall stress based on LaPlace’s Law for cylinders. Our published studies showed that diameter was a poor predictor of wall stress due to the complexity of individual aTAA geometries. We propose to prospectively evaluate changes in aTAA wall stresses and distensibility to determine their ability to improve on diameter criterion to predict dissection or death or need for surgery in veterans with aneurysms that do not meet criteria for surgery. We propose to prospectively evaluate changes in aneurysm wall shear stresses, flow velocities, and vortices in veterans with nonsurgical sized aTAAs over time to determine their ability to predict aneurysm growth and need for surgery. This proposal lays the foundation for practical clinical application of patient-specific biomechanics and fluid dynamics to improve risk prediction of aortic dissection, sudden death, aTAA growth, and need for surgery with the following aims: Aim 1: To determine changes in longitudinal wall stresses using finite element analysis (FEA) to correlate with clinical composite endpoint of aortic dissection, need for surgical repair, or sudden death in prospectively followed veterans (n=400) with nonsurgical aTAA <5.5cm over 4 years. Aim 2: To determine changes in aTAA wall strength using the surrogate of in vivo aortic distensibility to correlate with clinical composite endpoint of aortic dissection, aTAA surgical repair, or sudden death in prospectively followed veterans (n=400) with nonsurgical aTAA <5.5cm over 4 years. Aim 3: To determine changes in aTAA circumferential wall stresses and wall shear stresses, flow velocities, and eccentricity using fluid structure interaction (FSI), validate with 4D flow magnetic resonance imaging (MRI), and correlate with clinical composite endpoint of aortic growth or need for surgical repair in prospectively followed veterans (n=400) with nonsurgical aTAA <5.5cm over 4 years. Aim 4: To develop a machine learning (ML) approach to determine biomechanical and fluid dynamic parameters in Aim 1-3 in prospectively followed veterans (n=320) with nonsurgical aTAA <5.5cm, validate the results (n=80), and simplify the process of personalized biomechanics prediction. At the end of the project, we will have developed a new biomechanics based clinical tool for effective clinical management for non-surgical aTAA patients.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
ShEEP Request for 3D Printer
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: